The Inflammation Panel 3 (cyno) Kit provides the assay-specific components for the quantitative determination of NGAL/lipocalin-2, tissue inhibitor of metalloproteinases (TIMP-1), and monocyte chemoattractant protein-1 (MCP-1) in cyno serum, plasma, and cell supernatant. Increased levels of these markers may play a pivotal role in the pathogenesis of inflammatory diseases such as atherosclerosis, rheumatoid arthritis, and acute kidney injury. TIMP-1 and NGAL/lipocalin-2 expression can indicate inflammatory action following infection, ischemia, and endotoxic insults to the endothelium and stromal matrix. MCP-1 is uniformly upregulated at sites of vascular disease or injury and is one of the earliest cellular responses to atherogenesis.
-
-
Specifications
-
Kit Contents
-
References
-
Documentation
|
Application(s)
|
|
Toxicology
|
|
|
Analyte(s)
|
|
MCP-1, NGAL/LCN2, TIMP-1
|
|
|
Species
|
|
Non-human primate
|
|
|
Instrument
|
|
MESO QuickPlex SQ 120
,
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Inflammation Panel 3 (cyno) Calibrator Blend
|
≤-70°C
|
1 vial
(20 μL)
|
|
|
|
SULFO-TAG Anti-human TIMP-1 Antibody
|
2-8°C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human NGAL Antibody
|
2-8°C
|
1 vial
(75 μL)
|
|
|
|
SULFO-TAG Anti-human MCP-1 Antibody
|
2-8°C
|
1 vial
(75 μL)
|
|
|
|
Inflammation Panel 3 (cyno) Plate
|
2-8°C
|
1 each
(1 each)
|
|
|
|
|
≤-10°C
|
1 each
(50 mL)
|
|
|
|
|
≤-10°C
|
1 bottle
(5 mL)
|
|
|
|
|
RT
|
1 each
(50 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 each
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 each
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Inflammation Panel 3 (cyno) Calibrator Blend
|
≤-70°C
|
5 vial
(20 μL)
|
|
|
|
SULFO-TAG Anti-human TIMP-1 Antibody
|
2-8°C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human NGAL Antibody
|
2-8°C
|
1 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human MCP-1 Antibody
|
2-8°C
|
1 vial
(375 μL)
|
|
|
|
Inflammation Panel 3 (cyno) Plate
|
2-8°C
|
5 each
(1 each)
|
|
|
|
|
≤-10°C
|
4 each
(50 mL)
|
|
|
|
|
≤-10°C
|
5 bottle
(5 mL)
|
|
|
|
|
RT
|
1 each
(50 mL)
|
|
|
|
MSD Blocker A
|
RT
|
1 each
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
1 each
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Inflammation Panel 3 (cyno) Calibrator Blend
|
≤-70°C
|
25 vial
(20 μL)
|
|
|
|
SULFO-TAG Anti-human TIMP-1 Antibody
|
2-8°C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human NGAL Antibody
|
2-8°C
|
5 vial
(375 μL)
|
|
|
|
SULFO-TAG Anti-human MCP-1 Antibody
|
2-8°C
|
5 vial
(375 μL)
|
|
|
|
Inflammation Panel 3 (cyno) Plate
|
2-8°C
|
25 each
(1 each)
|
|
|
|
|
≤-10°C
|
20 each
(50 mL)
|
|
|
|
|
≤-10°C
|
25 bottle
(5 mL)
|
|
|
|
|
RT
|
5 each
(50 mL)
|
|
|
|
MSD Blocker A
|
RT
|
5 each
(250 mL)
|
|
|
|
MSD Phosphate Buffer
5X
|
RT
|
5 each
(50 mL)
|
|
|
|
Title
|
Journal
|
Year
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease
|
|
|
|
Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy.
|
|
|
|
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
|
|
|
|
|
View All
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Kit Layout (Add-in)
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters